The current study indicates PGG potential as an anti-cancer compound, inhibiting the expression of TNFα-induced CXCL1 via inhibition of the expression of genes and proteins involved in the NFқB and MAPK signaling in MM-231 and MM-468 TNBC cell lines. The gene discussed is CXCL1; the disease is cancer.